BioVaxys Technology Corp.
BVAXF · OTC
10/31/2024 | 10/31/2023 | 10/31/2022 | 10/31/2021 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$3,955 | -$7,687 | -$11,727 | -$6,458 |
| Dep. & Amort. | $0 | $0 | $0 | $0 |
| Deferred Tax | $0 | $0 | $0 | $0 |
| Stock-Based Comp. | $302 | $151 | $500 | $1,137 |
| Change in WC | $54 | $2,189 | $1,904 | -$83 |
| Other Non-Cash | $1,737 | $4,293 | $7,749 | $110 |
| Operating Cash Flow | -$1,862 | -$1,055 | -$1,575 | -$5,294 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | -$1,056 | $0 | $0 | $0 |
| Net Acquisitions | $0 | $0 | $0 | $0 |
| Inv. Purchases | $0 | $0 | $0 | $0 |
| Inv. Sales/Matur. | $0 | $0 | $0 | $0 |
| Other Inv. Act. | $0 | $0 | $0 | $0 |
| Investing Cash Flow | -$1,056 | $0 | $0 | $0 |
| Financing Activities | – | – | – | – |
| Debt Repay. | -$33 | $0 | $0 | -$370 |
| Stock Issued | $3,161 | $917 | $1,108 | $3,060 |
| Stock Repurch. | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | $0 | $0 | $0 | $748 |
| Financing Cash Flow | $3,127 | $917 | $1,108 | $3,439 |
| Forex Effect | $2 | -$3 | $15 | $25 |
| Net Chg. in Cash | $211 | -$141 | -$451 | -$1,830 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $1 | $142 | $593 | $2,423 |
| End Cash | $212 | $1 | $142 | $593 |
| Free Cash Flow | -$2,919 | -$1,055 | -$1,575 | -$5,294 |